{
    "id": 25853,
    "fullName": "PTK6 T264M",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "PTK6 T264M lies within the protein kinase domain of the Ptk6 protein (UniProt.org). T264M results in increased Ptk6 kinase activity in cell culture and is associated with Ptk6 inhibitor resistance (PMID: 27758886).",
            "references": [
                {
                    "id": 7466,
                    "pubMedId": 27758886,
                    "title": "Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27758886"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5753,
        "geneSymbol": "PTK6",
        "terms": [
            "PTK6",
            "BRK"
        ]
    },
    "variant": "T264M",
    "createDate": "01/03/2017",
    "updateDate": "06/30/2018",
    "referenceTranscriptCoordinates": {
        "id": 169036,
        "transcript": "NM_005975",
        "gDna": "chr20:g.63532567G>A",
        "cDna": "c.791C>T",
        "protein": "p.T264M",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 9679,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing PTK6 T264M demonstrated resistance to signaling and growth inhibition by XMU-MP-2 in culture and in xenograft models (PMID: 27758886).",
            "molecularProfile": {
                "id": 26968,
                "profileName": "PTK6 T264M"
            },
            "therapy": {
                "id": 5154,
                "therapyName": "XMU-MP-2",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 7466,
                    "pubMedId": 27758886,
                    "title": "Targeting BRK-Positive Breast Cancers with Small-Molecule Kinase Inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27758886"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 26968,
            "profileName": "PTK6 T264M",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 169036,
            "transcript": "NM_005975",
            "gDna": "chr20:g.63532567G>A",
            "cDna": "c.791C>T",
            "protein": "p.T264M",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}